| (Values in U.S. Thousands) | Dec, 2025 | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 |
| Sales | 1,853,640 | 1,716,600 | 1,596,670 | 1,376,100 | 1,221,080 |
| Sales Growth | +7.98% | +7.51% | +16.03% | +12.70% | +13.75% |
| Net Income | 102,810 | 119,900 | 90,650 | 66,380 | 96,810 |
| Net Income Growth | -14.25% | +32.27% | +36.56% | -31.43% | +25.30% |
Integer Holdings Corp (ITGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Integer Holdings Corporation manufactures and develops medical devices and components primarily for original equipment manufacturers, which depend on it to design, develop and produce intellectual property protected medical device technologies. Integer Holdings operates through two segments: Medical Sales and Non-Medical Sales. Medical Sales has three sub-segments Advanced Surgical, Orthopedics and Portable Medical; Cardio and Vascular; and Cardiac Rhythm Management & Neuromodulation.
Fiscal Year End Date: 12/31